Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced that based on an August 11, 2016 discussion with the U.S.
Endo International plc – Ordinary Shares (NASDAQ:ENDP) reported second quarter 2016 financial results, including: Revenues of $921 million including the addition of sales …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) just raised the price on its pipeline drug, Vasostrict, a polypeptide hormone indicated to increase blood …
Healthcare analysts provide their insights on Endo International plc – Ordinary Shares (NASDAQ:ENDP) and Cytokinetics, Inc. (NASDAQ:CYTK) following a new patent and management …
Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced that one of its operating companies, Par Pharmaceutical, has been issued a new patent by the …
Endo Pharmaceuticals Inc., a subsidiary of Endo International plc – Ordinary Shares (NASDAQ:ENDP) announced that, based on discussions with the U.
Marinus Pharmaceuticals Inc Monday turned out to be a nightmare for shareholders of Marinus Pharmaceuticals Inc (NASDAQ:MRNS), as the stock price tumbled 70% following the news …
Endo Pharmaceuticals Inc., a subsidiary of Endo International plc – Ordinary Shares (NASDAQ:ENDP), announced new data to be presented supporting the safety and tolerability …
Analysts recently weighed in on two healthcare stocks Endo International plc – Ordinary Shares (NASDAQ:ENDP) and Galena Biopharma Inc (NASDAQ:GALE). While one analyst …
In light of recent 1Q earning results from pharmaceutical companies Endo International plc – Ordinary Shares (NASDAQ:ENDP), and Medivation Inc (NASDAQ:MDVN), Barclay’s analysts …
